It is now widely accepted that the cGAS-STING signaling cascade may rely primarily on synthetic interferons (IFNs) to exert anti-tumor effects, but recent studies have found that it also has significant regulatory effects on non-immune pathways and influences tumor progression. This evidence concerns the gene STING1 and neoplasm.